28
May
Deblistering: current regulatory framework in light of the new opinion issued by the Council of State
In recent years, the practice of deblistering has generated significant debate, largely due to the absence of a uniform national regulatory framework.
28
May
The new tariffs regime and the new Federal Orders by the US Trump administration: first initial thoughts on certain legal and operational impacts for EU pharmaceutical business
President Trump has announced specific tariffs on pharmaceutical products within next weeks.
28
May
Do users’ data processed by ecommerce operators qualify as health data? ECJ says yes
Health sector operators who sell their products, as well as third-party companies offering such intermediation services, process personal data provided by users during the ordering and purchasing phase.
28
May
Online sale of drugs: recent trends in EU case law
The promotion and online sale of medicinal products are subject to a series of regulatory provisions and constraints.
